Abstracts

Poster Presentation Dates

All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.

Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).

#	Title	Authors	Category	Keywords
P393	Single agent activity of a novel PD-1 inhibitor AGEN2034 in recurrent ovarian cancer. Subset analysis of phase I dose escalation NCT03104699 study	David M. O'Malley; John Hays; Charles Drescher; Jasgit Sachdev; Wilberto Nieves-Neira; Breelyn Wilky; Marylin Huang; Kathleen N. Moore; Waldo Ortuzar; Anna Wijatyk; Hagop Youssoufian; Remigiusz Kaleta, MD; Inbal Sapir; Christopher Dupont, PhD; Irina Shapiro; Debra Richardson, MD;	Clinical Trial In Progress	Biomarkers; Clinical study; Immune contexture; Solid tumors; Targeted therapy